Schizophrenia ; Cannabis
Showing 1 - 25 of 3,238
Schizophrenia, Cannabis Use Disorder Trial in Neuilly sur Marne, Neuilly-sur-Marne (tDCS)
Recruiting
- Schizophrenia
- Cannabis Use Disorder
- tDCS
-
Neuilly sur Marne, France
- +1 more
Mar 23, 2023
Schizophrenia, Cannabis Use Disorder Trial (Delta-9-THC, Placebo)
Not yet recruiting
- Schizophrenia
- Cannabis Use Disorder
- Delta-9-THC
- Placebo
- (no location specified)
Sep 21, 2023
Schizophrenia Trial in Bron (Cannabis and thought disorder in schizophrenia:clinical and neuroimaging relationships)
Recruiting
- Schizophrenia
- Cannabis and thought disorder in schizophrenia:clinical and neuroimaging relationships
-
Bron, Auvergne Rhone Alpes, FranceCentre Hospitalier Le Vinatier
Mar 15, 2022
Schizophrenia, Cannabis-Induced Disorder Trial in France (Transcranial direct current stimulation (tDCS) active, Transcranial
Not yet recruiting
- Schizophrenia
- Cannabis-Induced Disorder
- Transcranial direct current stimulation (tDCS) active
- Transcranial direct current stimulation (tDCS) non active
-
Bron, France
- +6 more
Nov 29, 2022
Psychotic Disorders, Cannabis Use Disorder, Cannabis Dependence Trial in Montréal (Contingency management)
Recruiting
- Psychotic Disorders
- +7 more
- Contingency management
-
Montréal, Quebec, CanadaDouglas Mental Health University Institute
Jun 30, 2022
Schizophrenia, Cannabis Use Trial in London (Cannabidiol, Placebo, Delta-9-THC)
Recruiting
- Schizophrenia
- Cannabis Use
- Cannabidiol
- +2 more
-
London, United KingdomSouth London and Maudsley NHS Foundation Trust
Aug 16, 2022
Psychosis, Schizophrenia, At-risk Mental State Trial (Language assessment, TLC - Scale for the Assessment of Thought, Language,
Not yet recruiting
- Psychosis
- +3 more
- Language assessment
- +3 more
- (no location specified)
Sep 12, 2023
Schizophrenia, Dual Diagnosis, Schizoaffective Disorder Trial in Lebanon (Dronabinol, Cannabis)
Completed
- Schizophrenia
- +4 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Jul 8, 2021
Psychosis, Cannabis Use, THC Trial in West Haven (Placebo, Very Low Dose THC, Low Dose THC)
Active, not recruiting
- Psychosis
- +4 more
- Placebo
- +2 more
-
West Haven, ConnecticutVA Connecticut Healthcare System
Jul 21, 2022
Psychosis, Substance Use, Substance Use Disorders Trial in Belmont (CRAFT-FT)
Completed
- Psychosis
- +14 more
- CRAFT-FT
-
Belmont, MassachusettsMcLean Hospital
Sep 16, 2022
Imaging Cannabinoid Receptors Using Positron Emission Tomography
Recruiting
- Schizophrenia
- +6 more
- [11-C]OMAR
-
New Haven, ConnecticutConnecticut Mental Health Center, Clinical Neuroscience Research
Feb 23, 2022
Schizophrenia Spectrum Disorders, Cannabis Use Trial in Los Angeles, Baltimore, Catonsville (Cannabidiol (CBD), Placebo)
Withdrawn
- Schizophrenia Spectrum Disorders
- Cannabis Use
- Cannabidiol (CBD)
- Placebo
-
Los Angeles, California
- +2 more
Apr 14, 2021
Psychosis, Substance Use, Substance Use Disorders Trial in Belmont (CRAFT-EP, TAU)
Recruiting
- Psychosis
- +10 more
- CRAFT-EP
- TAU
-
Belmont, MassachusettsMcLean Hospital
Jun 2, 2022
Dual Diagnosis Trial in Glostrup (Cannabidiol, Risperidone)
Recruiting
- Dual Diagnosis
-
Glostrup, DenmarkCenter for Neuropsychiatric Schizophrenia Research
Jun 7, 2021
Schizophrenia, Schizoaffective Disorder Trial in Pittsburgh (CET/PT, Treatment as Usual)
Completed
- Schizophrenia
- Schizoaffective Disorder
- CET/PT
- Treatment as Usual
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Apr 10, 2020
Psychotic Disorders, Cannabis Use Disorder, Mental Health Disorder Trial in Montréal (Avatar Intervention)
Active, not recruiting
- Psychotic Disorders
- +2 more
- Avatar Intervention
-
Montréal, Quebec, CanadaResearch center of the Institut universitaire en santé mentale d
Feb 17, 2023
Repetitive Transcranial Magnetic Stimulation (rTMS), Schizophrenia, Cannabis Use Disorder Trial in Toronto (Repetitive
Unknown status
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- +3 more
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- +2 more
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Nov 12, 2019
Cannabis-Related Disorder, Substance-Related Disorders, Schizophrenia Trial in United States (clozapine, risperidone)
Completed
- Cannabis-Related Disorder
- +3 more
-
Concord, New Hampshire
- +4 more
Jul 9, 2019
Schizophrenia, Schizoaffective Disorder, Substance Use Disorders Trial in Boston, Worcester, Chapel Hill (Brexpiprazole,
Recruiting
- Schizophrenia
- +2 more
- Brexpiprazole
- Treatment as Usual
-
Boston, Massachusetts
- +2 more
May 31, 2022
Cannabis Use Disorder Trial in Canada (iCanChange)
Not yet recruiting
- Cannabis Use Disorder
- iCanChange
-
Calgary, Alberta, Canada
- +4 more
Mar 31, 2022
Schizophrenia, Mental Disorders, Psychotic Disorders Trial in West Haven (THC and Iomazenil, Placebo (control))
Completed
- Schizophrenia
- +2 more
- THC and Iomazenil
- Placebo (control)
-
West Haven, ConnecticutVA Connecticut Healthcare System
Dec 2, 2022
Cannabis Use, MDD, Cognitive Impairment Trial in Toronto (Contingency Reinforcement, Non-Contingency Reinforcement)
Recruiting
- Cannabis Use
- +2 more
- Contingency Reinforcement
- Non-Contingency Reinforcement
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Mar 7, 2022
COMT Gene Polymorphism Trial in West Haven (delta 9 tetrahydrocannabinol)
Completed
- COMT Gene Polymorphism
- delta 9 tetrahydrocannabinol
-
West Haven, ConnecticutVA Connecticut Healthcare System
Feb 23, 2022
Mental Illness, Schizophrenia, Bipolar Disorder Trial in Halifax (Genetic counselling)
Unknown status
- Mental Illness
- +5 more
- Genetic counselling
-
Halifax, Nova Scotia, CanadaNova Scotia Health Authority
Jul 22, 2019